Anne Voss

  • J. B. Winsløws Vej 19, 2.

    5000 Odense C

    Denmark

1990 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Fingerprint Dive into the research topics where Anne Voss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Population Medicine & Life Sciences
Denmark Medicine & Life Sciences
Prospective Studies Medicine & Life Sciences
Cutaneous Lupus Erythematosus Medicine & Life Sciences
Neuromyelitis Optica Medicine & Life Sciences
Lupus Nephritis Medicine & Life Sciences
Granulomatosis with Polyangiitis Medicine & Life Sciences
Advisory Committees Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

49 Downloads (Pure)

Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation

Guterbaum, T. J., Husic, M., Voss, A. & Dahl, J. S., 1. Apr 2019, In : The American journal of case reports. 20, p. 423-429

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Granulomatosis with Polyangiitis
Antineutrophil Cytoplasmic Antibodies
Churg-Strauss Syndrome
Mitral Valve
Respiratory System

Associations of circulating cell-free microRNA with vasculopathy and vascular events in systemic lupus erythematosus patients

Kay, S., Carlsen, A., Voss, A., Burton, M., Diederichsen, ACP., Poulsen, M. K. & Heegaard, NHH., Jan 2019, In : Scandinavian Journal of Rheumatology. 48, 1, p. 32-41

Research output: Contribution to journalJournal articleResearchpeer-review

MicroRNAs
Autoimmunity
Cluster Analysis
Real-Time Polymerase Chain Reaction
Cross-Sectional Studies

Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus Erythematosus

Troldborg, A., Steffensen, R., Trendelenburg, M., Hauser, T., Winther, K. G., Hansen, A. G., Stengaard-Pedersen, K., Voss, A. & Thiel, S., 15. May 2019, In : Journal of Clinical Immunology. 39, 4, p. 421-429

Research output: Contribution to journalJournal articleResearchpeer-review

Gene Deletion
Mutation

Reumatiske sygdomme

Deleuran, B. W., Schiøttz-Christensen, B., Voss, A., Sørensen, I. J., Madsen, O. R., Østergaard, M. & Hauge, E. M., 2019, Medicinsk Kompendium. de Muckadell, O. B. S., Hastrup Svendsen, J. & Vilstrup, H. (eds.). 19. ed. Munksgaard , Vol. 2. p. 1795-1983

Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

18 Downloads (Pure)

The impact of belimumab and rituximab on health-related quality of life in patients with systemic lupus erythematosus

Parodis, I., Lopez Benavides, A. H., Zickert, A., Pettersson, S., Möller, S., Welin Henriksson, E., Voss, A. & Gunnarsson, I., Jun 2019, In : Arthritis Care & Research. 71, 6, p. 811-821

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Quality of Life
Health
belimumab
Population Control
Mental Health

Activities 2004 2013

Polymyalgia rheumatica

Anne Voss (Lecturer)
9 Oct 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

SLE og morbus Sjögren

Anne Voss (Lecturer)
30 Sep 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Highligths in Rheumatology

Anne Voss (Lecturer)
20 Sep 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Systemisk lupus erythematosus

Anne Voss (Lecturer)
3 Sep 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Chairman ved afskedssymposium for professor Peter Junker, Klinisk Institut, Syddansk Universitet

Anne Voss (Other)
29 Aug 2013

Activity: Talks and presentationsTalks and presentations in private or public companies

Press / Media

Forbedret behandling af SLE - lupus

Anne Voss

11/08/2010

1 Media contribution

Press/Media: Press / Media

Nye behandlingsmuligheder for SLE - lupus

Anne Voss

18/06/2010

1 Media contribution

Press/Media: Press / Media